QuberTech, a UK biotechnology company developing sustainable natural rubber from specially engineered dandelions, has raised £3.4 million in combined grant funding and equity investment to accelerate …
Danish biotech startup Alcolase has raised €1.5 million with investment from Ada Ventures, Delphinus Venture Capital, Antler, Manigoff Invest and a group of business angels. Alcolase is developing an…
Cambridge-based biotechstartup Tolemy Bio has raised €1.4 million in pre-seed funding to advance itsAI-enabled technology for cell biology research and biopharma development. Theround was led by Norrs…
German-based deeptech startup NanoStruct has raised €2.6 million Seed funding. Founded by Dr Henriette Maaß, Enno Schatz, and Kai Leibfried, the company develops nanostructured sensor chips for the…
Glasgow-basedlife sciences company EnteroBiotix has secured £19 million in funding tosupport the advancement of its microbiome-based therapies, including a large-scale clinical trial targeting irritab…
Helical, a biotechnologycompany developing a virtual AI lab for pharmaceutical research anddevelopment, has raised $10 million in seed funding. The round was led byredalpine, with participation from G…
Generare,a Paris-based biotechnology company focused on generating molecular data fordrug development, has raised €20 million in a Series A funding round. The roundwas co-led by Alven and Daphni, with…
Semarion, a University ofCambridge spin-out from the Cavendish Laboratory, has raised $3.8 million (£2.9million) in funding to support the expansion of its cell-based screeningtechnology. The round wa…
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
Berlin-founded biotech startup Cellbricks Therapeutics has raised €10 million to advance its goal of 3D-printed organs, beginning with biofabricated human tissue implants. If successful, Cellbricks i…